Global pharma M&A tumult expected as US tariffs threaten supply chain – Mergermarket article quoting Ali Pashazadeh, Treehill Partners CEO

Global pharma M&A tumult expected as US tariffs threaten supply chain – Mergermarket article quoting Ali Pashazadeh, Treehill Partners CEO

In this article, Mergermarket reporters Jonathan Smith, Christel Thunnel and Izaz Ansari address how US-based manufacturing capacity crucial but targets are scarce and expensive, acquisitions of commercial-stage assets are slow, and opportunities for first mover-companies.

The article provides deep insight into M&A in our industry, quoting Ali Pashazadeh, Treehill Partners CEO, amongst other KOLs.

Read the full article: https://mergermarket.ionanalytics.com/content/1004229766?source=news

(subscription required)

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.